DVS Diabetes Ltd - Accounts


2022-01-01 2022-12-31 true No description of principal activity Capium Accounts Production 1.1 10535762 bus:FullAccounts 2022-01-01 2022-12-31 10535762 bus:FRS102 2022-01-01 2022-12-31 10535762 bus:AuditExempt-NoAccountantsReport 2022-01-01 2022-12-31 10535762 bus:SmallCompaniesRegimeForAccounts 2022-01-01 2022-12-31 10535762 bus:PrivateLimitedCompanyLtd 2022-01-01 2022-12-31 10535762 2022-01-01 2022-12-31 10535762 2022-12-31 10535762 bus:RegisteredOffice 2022-01-01 2022-12-31 10535762 core:WithinOneYear 2022-12-31 10535762 core:AfterOneYear 2022-12-31 10535762 bus:Director1 2022-01-01 2022-12-31 10535762 bus:Director1 2022-12-31 10535762 bus:Director1 2021-01-01 2021-12-31 10535762 2021-01-01 10535762 bus:CompanySecretary1 2022-01-01 2022-12-31 10535762 bus:LeadAgentIfApplicable 2022-01-01 2022-12-31 10535762 2021-01-01 2021-12-31 10535762 2021-12-31 10535762 core:WithinOneYear 2021-12-31 10535762 core:AfterOneYear 2021-12-31 10535762 bus:EntityAccountantsOrAuditors 2021-01-01 2021-12-31 10535762 bus:OrdinaryShareClass1 2022-01-01 2022-12-31 10535762 bus:OrdinaryShareClass1 2022-12-31 10535762 bus:OrdinaryShareClass1 2021-01-01 2021-12-31 10535762 bus:OrdinaryShareClass1 2021-12-31 10535762 core:CostValuation core:Non-currentFinancialInstruments 2022-12-31 10535762 core:CostValuation core:Non-currentFinancialInstruments 2021-12-31 10535762 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2022-12-31 10535762 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2022-12-31 10535762 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2022-12-31 10535762 core:Non-currentFinancialInstruments 2022-12-31 10535762 core:Non-currentFinancialInstruments 2021-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10535762
England and Wales

 

 

 

DVS DIABETES LTD


Dormant Accounts
 


Period of accounts

Start date: 01 January 2022

End date: 31 December 2022
Director Nova Group Holdings Limited
Registered Number 10535762
Registered Office 57 Jordan Street
LIVERPOOL ENGLAND
LIVERPOOL
Merseyside
L1 0BW
1
The directors present his/her/their annual report and the financial statements for the year ended 31 December 2022.
The company is dormant and has not traded during the year.
Director

The directors who served the company throughout the year were as follows:
Nova Group Holdings Limited

This report was approved by the board and signed on its behalf by:


----------------------------------
Nova Group Holdings Limited
Director

Date approved: 20 September 2023
2
 
 
Notes
 
2022
£
  2021
£
Current assets      
Net current assets  
 
Total assets less current liabilities  
Net assets  
 

Capital and reserves
     
Shareholder's funds  
 


For the year ended 31 December 2022 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of Part 15 of the Companies Act 2006. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 20 September 2023 and were signed on its behalf by:


-------------------------------
Nova Group Holdings Limited
Director
3
General Information
DVS Diabetes Ltd is a private company, limited by shares, registered in England and Wales, registration number 10535762, registration address 57 Jordan Street, LIVERPOOL ENGLAND, LIVERPOOL, Merseyside, L1 0BW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Share Capital

Allotted, called up and fully paid
2022
£
  2021
£
2 Class A shares of £0.01 each  
 

3.

Average number of employees

Average number of employees during the year was 0 (2021 : 0).
4